RETRACTION article

Front. Neurol., 27 February 2019

Sec. Neuropharmacology

Volume 10 - 2019 | https://doi.org/10.3389/fneur.2019.00255

Retraction: Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression

The Journal and Chief Editors retract the October 2017 article cited above.

Following the publication of the article, concerns with the study's methodology were addressed to the Journal and its Editorial Board. Despite extensive efforts to clarify these with the authors and their institution, we have not been able to obtain a response. Therefore, following further independent assessment of the concerns raised, the Journal retracts the article, without the authors' agreement, due to these concerns.

Summary

Keywords

curcumin,, Alzheimer’s disease,, Pi(3,5)P2, , transient receptor potential mucolipin-1, Aβ1-42

Citation

Frontiers Editorial Office (2019) Retraction: Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression. Front. Neurol. 10:255. doi: 10.3389/fneur.2019.00255

Received

26 February 2019

Accepted

26 February 2019

Published

27 February 2019

Approved by

Nicholas M. Barnes, University of Birmingham, United Kingdom

Volume

10 - 2019

Updates

Copyright

*Correspondence: Frontiers Editorial Office

This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neurology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics